NCT05853991

Brief Summary

Improving the quality of life of preterm children by 2035 is the top priority of worldwide health organisations, including the WHO. Every year, 15 million preterm infants, particularly those under 32 weeks of age, are at significant risk of neurocognitive impairments with adverse health consequences (disability, developmental delay, disease), exacerbated by the lack of post-hospital care for newborns. Intervening on the health of the preterm newborn through certain types of "touch" from its first days of life to activate its cutaneous senses permits, in reality, a significant improvement in the clinical state of the infant, hence promoting its growth, development, and social behaviour. In the neonatal period, during which significant neurological development occurs, tactile interactions and close physical proximity between infants and caregivers have significant short-term effects on the health of premature infants (weight gain, brain and vision development) and medium- to long-term effects on their development and expression of sociability. The likelihood that a premature newborn may develop attention and autism spectrum disorders, brain, gastrointestinal, and respiratory difficulties, as well as sleep disorders during the preschool years, is so high that clinical and social settings must prioritise care. Utilizing functional magnetic resonance imaging (fRMI), computerized electroencephalogram (EEG), and metabolomics, the research aims to explore the effects of touch, including physiotherapy and manual therapy (OMT) approaches, on brain activity. This research intends to examine the impact of touch on premature infants' brain activity (physical biomarker) and metabolic activity (biological biomarker).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 7, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

May 11, 2023

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

May 17, 2023

Status Verified

May 1, 2023

Enrollment Period

1.8 years

First QC Date

February 7, 2023

Last Update Submit

May 16, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • brain changes

    pre-post changes in BOLD levels among different brain areas

    1 hour

Secondary Outcomes (16)

  • electroencephalogram (EEG) changes

    10 days

  • Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) at T1

    1 hour

  • Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) at T2

    4 days

  • Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) at T3

    8 days

  • Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) at T4

    12 days

  • +11 more secondary outcomes

Study Arms (3)

Therapeutic touch

EXPERIMENTAL

The intervention will be based on 2 phases: 1) assessment to identify areas following the NAME procedure, 2) treatment to improve the function of the area identified

Other: osteopathic manipulative treatment

Affective touch

ACTIVE COMPARATOR

Participants will receive an affective touch intervention following the standardised procedure for affective touch

Other: Active comparator

Static touch

PLACEBO COMPARATOR

Participants will receive a static touch intervention following the standardised procedure for static touch

Other: Placebo

Interventions

The intervention will be based on the specific assessment and treatment of the preterm developed by the team and validated through different studies.

Therapeutic touch

Application of affective touch

Affective touch
PlaceboOTHER

Application of static touch

Static touch

Eligibility Criteria

Age32 Weeks - 34 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Preterm birth, between 32.0 and 33.6 weeks gestational age (GA);
  • Absence of comorbidities that could affect the stability of vital parameters, and therefore represent a contraindication to the proposed intervention. Comorbities include sepsis, pathologies pertaining to surgery, respiratory or cardiovascular instability, birth from a drug-addicted or HIV-positive mother) or known congenital pathologies;
  • Obtaining informed consent for participation in this research project from parents or legal guardians.

You may not qualify if:

  • Preterm infants born before 32.0 weeks of GA and after 34 weeks and with respiratory and neurological pathologies and any additional comorbities.
  • Children whose parents will not read and sign or in case of failure to obtain informed consent will be excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ospedale dei bambini "Vittore Buzzi"

Milan, Italy

Location

Related Publications (1)

  • Manzotti A, Cerritelli F, Lombardi E, Tansini L, Pisanu D, Di Leo D, Vergani E, Righini A, Arrigoni F, Fanos V, Rescigno M, Veggiotti P, Lista G, Gazzolo D. Impact of touch interventions on brain activity in moderately preterm infants: study protocol for a pilot randomised controlled trial. BMJ Open. 2025 Oct 27;15(10):e102964. doi: 10.1136/bmjopen-2025-102964.

MeSH Terms

Conditions

Premature BirthDisease

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 7, 2023

First Posted

May 11, 2023

Study Start

June 1, 2023

Primary Completion

March 1, 2025

Study Completion

March 1, 2026

Last Updated

May 17, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations